Correlation Between Femasys and Heart Test

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Femasys and Heart Test at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Femasys and Heart Test into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Femasys and Heart Test Laboratories, you can compare the effects of market volatilities on Femasys and Heart Test and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Femasys with a short position of Heart Test. Check out your portfolio center. Please also check ongoing floating volatility patterns of Femasys and Heart Test.

Diversification Opportunities for Femasys and Heart Test

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Femasys and Heart is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Femasys and Heart Test Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heart Test Laboratories and Femasys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Femasys are associated (or correlated) with Heart Test. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heart Test Laboratories has no effect on the direction of Femasys i.e., Femasys and Heart Test go up and down completely randomly.

Pair Corralation between Femasys and Heart Test

Given the investment horizon of 90 days Femasys is expected to under-perform the Heart Test. But the stock apears to be less risky and, when comparing its historical volatility, Femasys is 53.94 times less risky than Heart Test. The stock trades about -0.04 of its potential returns per unit of risk. The Heart Test Laboratories is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest  8.00  in Heart Test Laboratories on September 1, 2024 and sell it today you would lose (4.99) from holding Heart Test Laboratories or give up 62.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy39.36%
ValuesDaily Returns

Femasys  vs.  Heart Test Laboratories

 Performance 
       Timeline  
Femasys 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Femasys are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Femasys may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Heart Test Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Solid
Over the last 90 days Heart Test Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly uncertain basic indicators, Heart Test showed solid returns over the last few months and may actually be approaching a breakup point.

Femasys and Heart Test Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Femasys and Heart Test

The main advantage of trading using opposite Femasys and Heart Test positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Femasys position performs unexpectedly, Heart Test can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will offset losses from the drop in Heart Test's long position.
The idea behind Femasys and Heart Test Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators